AI-generated summary
This review outlines the use, dosage, safety, and efficacy of narrowband UVB and targeted phototherapy for psoriasis. The authors report that NB-UVB and excimer laser are effective options, that long-term NB-UVB data indicate a good safety profile, and that robust data on combining phototherapy with biologic agents or phosphodiesterase inhibitors are lacking.
- Who or what was studied
- Patients with psoriasis, particularly those with more than 10% affected body surface area who have not responded to topical treatments
- Limits stated in the abstract
- The abstract does not state the number of studies included, and it notes that robust data on some combination treatments are lacking.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Phototherapy, Ultraviolet, Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.